APCCC 2017 Conference VL

Should AR-V7 Be Used As A Clnical Test? - Philip Kantoff

Details
Phillip Kantoff, MD provides his perspective on the role of AR-V7 as a clincial test. (Presentation in 10 minutes). Biography: Philip Kantoff, MD., is the Chair, Department of Medicine; The George J. Bosl Chair Memorial Sloan Kettering Cancer Center. He is a board-certified medical oncologist and researcher specializing in the treatment of genitourinary cancers. His lab focuses on understanding th...

Treatment of M1 Disease No Local Treatment - Nicolas Mottet

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Patients with Familial Prostate Cancer: Practical Implications and Recommendations - Ros Eeles

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy - Noel Clarke

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Debate: Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy. Yes! - Fred Saad

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy - Cora Sternberg

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Tumor Biopsy in Men With Metastatic Prostate Cancer: What Should the Pathologist Report? - Mark Rubin

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

M0 CRPC: Clinical Entity or Diagnostic Dilemma - Brett Carver

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Adverse Effects of Androgen Deprivation Therapy - Matthew R. Smith

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Managing the ‘Start’ and ‘Stop’ of Various Therapies for Treating CRPC Patients - Is Timing Everything?- Karim Fizazi

Details
(Length of lecture - 15 minutes) Dr. Karim Fizazi discusses the 2015 APCCC, and the uncertainty during that period around the optimal timing to initiate treatment to men with CRPC. Two years later, Dr. Fizazi presents clinical trial data that has been gathered since then on different therapy options and shares his opinion on the recommended start and stop intervals for administering these therapie...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe